activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Not Active	1650837	CHEMBL861050	Average Binding Constant for STK38L; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4851	Homo sapiens	Kd		
Not Active	1650837	CHEMBL861050	Average Binding Constant for STK38L; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4851	Homo sapiens	Kd		
	1650838	CHEMBL861050	Average Binding Constant for STK38L; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	3100.0	CHEMBL4851	Homo sapiens	Kd	uM	3.1
Not Active	1650839	CHEMBL861050	Average Binding Constant for STK38L; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL4851	Homo sapiens	Kd		
	1650840	CHEMBL861050	Average Binding Constant for STK38L; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1500.0	CHEMBL4851	Homo sapiens	Kd	uM	1.5
Not Active	1650841	CHEMBL861050	Average Binding Constant for STK38L; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL4851	Homo sapiens	Kd		
Not Active	1650842	CHEMBL861050	Average Binding Constant for STK38L; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL4851	Homo sapiens	Kd		
Not Active	1650843	CHEMBL861050	Average Binding Constant for STK38L; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL4851	Homo sapiens	Kd		
Not Active	1650844	CHEMBL861050	Average Binding Constant for STK38L; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL4851	Homo sapiens	Kd		
Not Active	1650845	CHEMBL861050	Average Binding Constant for STK38L; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL4851	Homo sapiens	Kd		
	1651863	CHEMBL861050	Average Binding Constant for STK38L; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	77.0	CHEMBL4851	Homo sapiens	Kd	uM	0.077
Not Active	1651864	CHEMBL861050	Average Binding Constant for STK38L; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL4851	Homo sapiens	Kd		
Not Active	1651865	CHEMBL861050	Average Binding Constant for STK38L; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL4851	Homo sapiens	Kd		
Not Active	1651866	CHEMBL861050	Average Binding Constant for STK38L; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL4851	Homo sapiens	Kd		
Not Active	1651867	CHEMBL861050	Average Binding Constant for STK38L; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL4851	Homo sapiens	Kd		
	1651868	CHEMBL861050	Average Binding Constant for STK38L; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Kd	nM	2300.0	CHEMBL4851	Homo sapiens	Kd	uM	2.3
Not Active	1651869	CHEMBL861050	Average Binding Constant for STK38L; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL4851	Homo sapiens	Kd		
Not Active	1651870	CHEMBL861050	Average Binding Constant for STK38L; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL4851	Homo sapiens	Kd		
Not Active	1651871	CHEMBL861050	Average Binding Constant for STK38L; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL4851	Homo sapiens	Kd		
Not Active	1651872	CHEMBL861050	Average Binding Constant for STK38L; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828		Kd			CHEMBL4851	Homo sapiens	Kd		
Not Active	1651873	CHEMBL861050	Average Binding Constant for STK38L; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL4851	Homo sapiens	Kd		
	2470291	CHEMBL987211	Inhibition of NDR2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4851	Homo sapiens	INH	%	10.0
Not Evaluated	2476706	CHEMBL982734	Binding affinity to human NDR2 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL4851	Homo sapiens	Activity		
Not Evaluated	2478545	CHEMBL982734	Binding affinity to human NDR2 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL4851	Homo sapiens	Activity		
	2478748	CHEMBL982734	Binding affinity to human NDR2 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	27.4	CHEMBL4851	Homo sapiens	Activity	%	27.4
Not Evaluated	2479603	CHEMBL982734	Binding affinity to human NDR2 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL4851	Homo sapiens	Activity		
	2479806	CHEMBL982734	Binding affinity to human NDR2 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	30.7	CHEMBL4851	Homo sapiens	Activity	%	30.7
Active	2480603	CHEMBL982734	Binding affinity to human NDR2 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL4851	Homo sapiens	Activity		
	2480805	CHEMBL982734	Binding affinity to human NDR2 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	26.7	CHEMBL4851	Homo sapiens	Activity	%	26.7
Not Evaluated	2577224	CHEMBL982734	Binding affinity to human NDR2 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL4851	Homo sapiens	Activity		
	2577427	CHEMBL982734	Binding affinity to human NDR2 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337	=	Activity	%	33.7	CHEMBL4851	Homo sapiens	Activity	%	33.7
Not Evaluated	2593632	CHEMBL982734	Binding affinity to human NDR2 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL4851	Homo sapiens	Activity		
Not Evaluated	2593898	CHEMBL982734	Binding affinity to human NDR2 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL4851	Homo sapiens	Activity		
Not Evaluated	2594101	CHEMBL982734	Binding affinity to human NDR2 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL4851	Homo sapiens	Activity		
Not Evaluated	2594841	CHEMBL982734	Binding affinity to human NDR2 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL4851	Homo sapiens	Activity		
Not Evaluated	2595044	CHEMBL982734	Binding affinity to human NDR2 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL4851	Homo sapiens	Activity		
Not Evaluated	2596241	CHEMBL982734	Binding affinity to human NDR2 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL4851	Homo sapiens	Activity		
Not Evaluated	2596444	CHEMBL982734	Binding affinity to human NDR2 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL4851	Homo sapiens	Activity		
Not Evaluated	2597713	CHEMBL982734	Binding affinity to human NDR2 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL4851	Homo sapiens	Activity		
	2902740	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902741	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902742	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902743	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902744	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902745	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902746	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902747	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902748	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902749	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902750	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902751	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902752	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902753	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902754	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902755	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902756	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902757	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902758	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902759	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902760	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902761	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902762	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902763	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902764	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902765	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902766	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902767	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902768	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902769	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902770	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902771	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902772	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	28.0	CHEMBL4851	Homo sapiens	Kd	nM	28.0
	2902773	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	2000.0	CHEMBL4851	Homo sapiens	Kd	nM	2000.0
	2902774	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	970.0	CHEMBL4851	Homo sapiens	Kd	nM	970.0
	2902775	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902776	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2902777	CHEMBL1060252	Binding constant for NDR2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	2921246	CHEMBL1048292	Inhibition of NDR2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL4851	Homo sapiens	Activity	%	100.0
	3332051	CHEMBL1166589	Inhibition of NDR2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4851	Homo sapiens	INH	%	50.0
	3333466	CHEMBL1166589	Inhibition of NDR2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4851	Homo sapiens	INH	%	50.0
	3334871	CHEMBL1166589	Inhibition of NDR2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4851	Homo sapiens	INH	%	50.0
	3336291	CHEMBL1166589	Inhibition of NDR2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4851	Homo sapiens	INH	%	50.0
	3337593	CHEMBL1166589	Inhibition of NDR2 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4851	Homo sapiens	INH	%	50.0
	3338924	CHEMBL1166589	Inhibition of NDR2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4851	Homo sapiens	INH	%	50.0
	3339177	CHEMBL1166589	Inhibition of NDR2 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4851	Homo sapiens	INH	%	50.0
	3340480	CHEMBL1166589	Inhibition of NDR2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL4851	Homo sapiens	INH	%	50.0
	3341833	CHEMBL1166589	Inhibition of NDR2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4851	Homo sapiens	INH	%	50.0
	3343280	CHEMBL1166589	Inhibition of NDR2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4851	Homo sapiens	INH	%	50.0
	3358696	CHEMBL1174938	Inhibition of NDR2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	8.7	CHEMBL4851	Homo sapiens	INH	%	8.7
	3359138	CHEMBL1174938	Inhibition of NDR2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	11.0	CHEMBL4851	Homo sapiens	INH	%	11.0
	3445221	CHEMBL1244535	Binding affinity to NDR2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	370.0	CHEMBL4851	Homo sapiens	Kd	nM	370.0
	3448527	CHEMBL1244535	Binding affinity to NDR2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	3449468	CHEMBL1244535	Binding affinity to NDR2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	970.0	CHEMBL4851	Homo sapiens	Kd	nM	970.0
	3449757	CHEMBL1244535	Binding affinity to NDR2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	3450160	CHEMBL1244535	Binding affinity to NDR2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	3450816	CHEMBL1244535	Binding affinity to NDR2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	3451075	CHEMBL1244535	Binding affinity to NDR2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	uM	10.0
	5123814	CHEMBL1645758	Inhibition of NDR2 at 1 uM	B	CCN1C(=O)CCC(C)(C)c2ccc(Nc3ncc(Cl)c(Nc4c(F)cccc4C(=O)NC)n3)cc21		CHEMBL1644812	=	Inhibition	%	99.0	CHEMBL4851	Homo sapiens	INH	%	99.0
	6341097	CHEMBL1826023	Activity of NDR2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL4851	Homo sapiens	Activity	%	100.0
	7567509	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7567980	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7568448	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7568880	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	2000.0	CHEMBL4851	Homo sapiens	Kd	nM	2000.0
	7569023	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7569483	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7569955	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7570418	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7570845	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	970.0	CHEMBL4851	Homo sapiens	Kd	nM	970.0
	7570999	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7571456	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7571932	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7572395	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7572811	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	580.0	CHEMBL4851	Homo sapiens	Kd	nM	580.0
	7572980	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7573437	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7573913	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7574958	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7575419	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7575890	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7575913	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7576321	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7576932	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7577391	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7577897	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7578302	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7578940	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7579314	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7579796	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	1100.0	CHEMBL4851	Homo sapiens	Kd	nM	1100.0
	7580265	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7580668	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7581298	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7581683	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7581686	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7582157	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7582621	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7583021	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	6900.0	CHEMBL4851	Homo sapiens	Kd	nM	6900.0
	7584044	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7584515	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7584977	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7585381	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7585532	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7585940	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7586386	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7586857	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7587311	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7587493	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7587912	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7588365	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7588836	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7589287	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7589458	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7589882	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	370.0	CHEMBL4851	Homo sapiens	Kd	nM	370.0
	7590349	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7590823	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7591431	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7591853	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7592325	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7592809	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7593398	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	2100.0	CHEMBL4851	Homo sapiens	Kd	nM	2100.0
	7593833	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7594305	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7594336	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7594788	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7595366	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7595810	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7596313	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7596760	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7597338	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7597822	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7598292	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	7598734	CHEMBL1908789	Binding constant for NDR2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	28.0	CHEMBL4851	Homo sapiens	Kd	nM	28.0
	10839419	CHEMBL2015081	Inhibition of NDR2 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	2.0	CHEMBL4851	Homo sapiens	INH	%	2.0
	12172321	CHEMBL2215436	Inhibition of NDR2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	93.0	CHEMBL4851	Homo sapiens	Activity	%	93.0
	13434690	CHEMBL2424431	Inhibition of NDR2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL4851	Homo sapiens	INH	%	35.0
	13434691	CHEMBL2424431	Inhibition of NDR2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL4851	Homo sapiens	INH	%	35.0
	13434692	CHEMBL2424431	Inhibition of NDR2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL4851	Homo sapiens	INH	%	35.0
	13434693	CHEMBL2424431	Inhibition of NDR2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL4851	Homo sapiens	INH	%	35.0
	13434694	CHEMBL2424431	Inhibition of NDR2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL4851	Homo sapiens	INH	%	35.0
	13434695	CHEMBL2424431	Inhibition of NDR2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL4851	Homo sapiens	INH	%	35.0
	13434696	CHEMBL2424431	Inhibition of NDR2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL4851	Homo sapiens	INH	%	35.0
	13434697	CHEMBL2424431	Inhibition of NDR2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL4851	Homo sapiens	INH	%	35.0
	13434698	CHEMBL2424431	Inhibition of NDR2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL4851	Homo sapiens	INH	%	35.0
	13434699	CHEMBL2424431	Inhibition of NDR2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL4851	Homo sapiens	INH	%	35.0
	13434700	CHEMBL2424431	Inhibition of NDR2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL4851	Homo sapiens	INH	%	35.0
	13434701	CHEMBL2424431	Inhibition of NDR2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	<	Inhibition	%	35.0	CHEMBL4851	Homo sapiens	INH	%	35.0
	13439794	CHEMBL2429147	Competitive binding affinity to NDR2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4851	Homo sapiens	INH	%	50.0
	13442622	CHEMBL2429147	Competitive binding affinity to NDR2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	72.0	CHEMBL4851	Homo sapiens	INH	%	72.0
	13445627	CHEMBL2429147	Competitive binding affinity to NDR2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL4851	Homo sapiens	INH	%	50.0
	13451614	CHEMBL2429147	Competitive binding affinity to NDR2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL4851	Homo sapiens	INH	%	50.0
	15756800	CHEMBL3631486	Inhibition of STK38L (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	33.71	CHEMBL4851	Homo sapiens	INH	%	33.71
	15757923	CHEMBL3631486	Inhibition of STK38L (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	22.41	CHEMBL4851	Homo sapiens	INH	%	22.41
	15758902	CHEMBL3631486	Inhibition of STK38L (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	7.36	CHEMBL4851	Homo sapiens	INH	%	7.36
	16432018	CHEMBL3750172	Inhibition of human STK38L using [KKRNRRLSVA] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4851	Homo sapiens	IC50	uM	10.0
Inactive	17941956	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941957	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941958	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941959	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941960	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941961	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941962	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941963	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941964	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941965	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941966	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941967	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941968	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941969	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941970	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941971	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17941972	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Kd	nM	414.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	414.0
Inactive	17941973	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941974	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941975	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941976	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941977	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941978	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941979	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941980	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941981	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941982	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941983	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941984	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941985	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941986	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941987	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941988	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941989	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941990	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941991	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941992	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941993	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941994	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941995	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941996	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941997	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941998	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17941999	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942000	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942001	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942002	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942003	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942004	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942005	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942006	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942007	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942008	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942009	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942010	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942011	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942012	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942013	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942014	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942015	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942016	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942017	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942018	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942019	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942020	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942021	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942022	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942023	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942024	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942025	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942026	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942027	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942028	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942029	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942030	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942031	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942032	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942033	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942034	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942035	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942036	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942037	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942038	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Active	17942039	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	2137.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	2137.0
Inactive	17942040	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942041	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942042	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942043	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942044	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942045	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942046	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942047	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942048	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942049	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17942050	CHEMBL3991897	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL4851	Homo sapiens	Kd apparent	nM	30000.0
	18114227	CHEMBL4025267	Inhibition of wild-type human partial length NDR2 (N34 to E447 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL4851	Homo sapiens	Activity	%	100.0
	18153059	CHEMBL4034421	Inhibition of NDR2 Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	>	Inhibition	%	35.0	CHEMBL4851	Homo sapiens	INH	%	35.0
	18153264	CHEMBL4034420	Inhibition of NDR2 Lysine 1 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	2.5	CHEMBL4851	Homo sapiens	INH	%	2.5
	18203791	CHEMBL4044078	Inhibition of wild-type human partial length NDR2 (N34 to E447 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL4851	Homo sapiens	Activity	%	100.0
	18211540	CHEMBL4045773	Inhibition of NDR2 conserved Lys2 (DIKPDNLLLDAK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-27.9	CHEMBL4851	Homo sapiens	INH	%	-27.9
	18211541	CHEMBL4045772	Inhibition of NDR2 conserved Lys1 (DTGHIYAMKILR) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-15.8	CHEMBL4851	Homo sapiens	INH	%	-15.8
	18211917	CHEMBL4046013	Inhibition of NDR2 conserved Lys1 (DTGHIYAMKILR) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-21.3	CHEMBL4851	Homo sapiens	INH	%	-21.3
	18211918	CHEMBL4046014	Inhibition of NDR2 conserved Lys2 (DIKPDNLLLDAK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-51.6	CHEMBL4851	Homo sapiens	INH	%	-51.6
	18253879	CHEMBL4055224	Inhibition of wild-type human partial length NDR2 (N34 to E447 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL4851	Homo sapiens	Activity	%	100.0
	18253880	CHEMBL4055224	Inhibition of wild-type human partial length NDR2 (N34 to E447 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL4851	Homo sapiens	Activity	%	100.0
	18275130	CHEMBL4118422	Inhibition of NDR2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKPDNLLLDAK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl	Outside typical range	CHEMBL3883384	=	Inhibition	%	-25.0	CHEMBL4851	Homo sapiens	INH	%	-25.0
	18275131	CHEMBL4118422	Inhibition of NDR2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKPDNLLLDAK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl	Outside typical range	CHEMBL3884839	=	Inhibition	%	-46.4	CHEMBL4851	Homo sapiens	INH	%	-46.4
	18275132	CHEMBL4118422	Inhibition of NDR2 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKPDNLLLDAK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O	Outside typical range	CHEMBL1077979	=	Inhibition	%	-133.8	CHEMBL4851	Homo sapiens	INH	%	-133.8
	18440333	CHEMBL4157157	Binding affinity to wild-type human partial length NDR2 (N34 to E447 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	27.0	CHEMBL4851	Homo sapiens	Activity	%	27.0
	18484289	CHEMBL4185936	Binding affinity to wild-type human partial length NDR2 (N34 to E447 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	97.0	CHEMBL4851	Homo sapiens	Activity	%	97.0
	18484773	CHEMBL4185936	Binding affinity to wild-type human partial length NDR2 (N34 to E447 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	79.0	CHEMBL4851	Homo sapiens	Activity	%	79.0
	18653495	CHEMBL4230156	Inhibition of NDR2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	1.0	CHEMBL4851	Homo sapiens	INH	%	1.0
	18653496	CHEMBL4230156	Inhibition of NDR2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	-1.0	CHEMBL4851	Homo sapiens	INH	%	-1.0
	18655399	CHEMBL4230836	Binding affinity to wild-type human partial length NDR2 (N34 to E447 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	82.0	CHEMBL4851	Homo sapiens	Activity	%	82.0
	18751167	CHEMBL4263876	Inhibition of NDR2 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	3.0	CHEMBL4851	Homo sapiens	INH	%	3.0
	18752088	CHEMBL4264425	Binding affinity to wild-type human partial length NDR2 (N34 to E447 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	78.0	CHEMBL4851	Homo sapiens	Activity	%	78.0
	18858089	CHEMBL4307935	Binding affinity to wild-type human partial length NDR2 (N34 to E447 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	74.0	CHEMBL4851	Homo sapiens	Activity	%	74.0
	18892667	CHEMBL4314582	Inhibition of recombinant human NDR2 (83 to end residues) assessed as residual activity at 10 uM using RSRSRSRSRSRSRSR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	108.0	CHEMBL4851	Homo sapiens	Activity	%	108.0
	18919389	CHEMBL4322749	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged STK38L (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	759.0	CHEMBL4851	Homo sapiens	Kd	nM	759.0
	18919577	CHEMBL4322749	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged STK38L (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	>	Kd	nM	2000.0	CHEMBL4851	Homo sapiens	Kd	nM	2000.0
	18938333	CHEMBL4327893	Inhibition of human STK38L assessed as residual activity at 1 uM using KKRNRRLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	99.96	CHEMBL4851	Homo sapiens	Activity	%	99.96
	18938334	CHEMBL4327893	Inhibition of human STK38L assessed as residual activity at 1 uM using KKRNRRLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	98.97	CHEMBL4851	Homo sapiens	Activity	%	98.97
	18938738	CHEMBL4328257	Inhibition of human STK38L assessed as residual activity at 100 uM using KKRNRRLSVA as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4851	Homo sapiens	Activity	%	65.0
	18939124	CHEMBL4328621	Inhibition of human STK38L using KKRNRRLSVA as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.47	CHEMBL4851	Homo sapiens	IC50	10'-9M	1.47
	18958669	CHEMBL4333522	Binding affinity to wild-type human partial length NDR2 (N34 to E447 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	89.0	CHEMBL4851	Homo sapiens	Activity	%	89.0
	18964513	CHEMBL4335197	Inhibition of recombinant human NDR2 (83 to end residues) assessed as residual activity at 1 uM using RSRSRSRSRSRSRSR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	92.0	CHEMBL4851	Homo sapiens	Activity	%	92.0
	18964514	CHEMBL4335197	Inhibition of recombinant human NDR2 (83 to end residues) assessed as residual activity at 1 uM using RSRSRSRSRSRSRSR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	118.0	CHEMBL4851	Homo sapiens	Activity	%	118.0
	18972011	CHEMBL4337021	Inhibition of recombinant human NDR2 (83 to end residues) assessed as residual activity at 10 uM using RSRSRSRSRSRSRSR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	89.0	CHEMBL4851	Homo sapiens	Activity	%	89.0
Not Active	19040069	CHEMBL4351973	Inhibition of recombinant human NDR2 (83 to end residues) at 10 uM using RSRSRSRSRSRSRSR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4851	Homo sapiens	INH		
Active	19041295	CHEMBL4352556	Inhibition of human STK38L at 10 uM using KKRNRRLSVA as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4851	Homo sapiens	INH		
	19059713	CHEMBL4358014	Binding affinity to wild-type human partial length NDR2 (N34 to E447 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	93.0	CHEMBL4851	Homo sapiens	Activity	%	93.0
	19090278	CHEMBL4365852	Inhibition of wild-type human partial length NDR2 (N34 to E447 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	84.0	CHEMBL4851	Homo sapiens	Activity	%	84.0
	19092132	CHEMBL4366606	Inhibition of human STK38L at 100 nM using KKRNRRLSVA as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-2.59	CHEMBL4851	Homo sapiens	INH	%	-2.59
	19144672	CHEMBL4377688	Inhibition of recombinant human NDR2 (83 to end residues) at 1 uM using RSRSRSRSRSRSRSR as substrate measured after 120 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	20.0	CHEMBL4851	Homo sapiens	INH	%	20.0
	19146883	CHEMBL4378909	Inhibition of recombinant human NDR2 (83 to end residues) at 10 uM using RSRSRSRSRSRSRSR as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	-6.0	CHEMBL4851	Homo sapiens	INH	%	-6.0
	19147957	CHEMBL4379243	Inhibition of recombinant human NDR2 (83 to end residues) using RSRSRSRSRSRSRSR as substrate measured after 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4851	Homo sapiens	IC50	uM	10.0
	19159541	CHEMBL4382645	Binding affinity to wild-type human partial length NDR2 (N34 to E447 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	54.0	CHEMBL4851	Homo sapiens	Activity	%	54.0
	19191466	CHEMBL4389364	Inhibition of wild-type human partial length NDR2 (N34 to E447 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	100.0	CHEMBL4851	Homo sapiens	INH	%	100.0
	19192027	CHEMBL4389841	Inhibition of wild-type human partial length NDR2 (N34 to E447 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL4851	Homo sapiens	INH	%	100.0
	19200283	CHEMBL4391467	Binding affinity to wild-type human partial length NDR2 (N34 to E447 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	99.0	CHEMBL4851	Homo sapiens	Activity	%	99.0
	19266631	CHEMBL4405581	Inhibition of wild-type human partial length NDR2 (N34 to E447 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4851	Homo sapiens	INH	%	50.0
	19276059	CHEMBL4408062	Inhibition of recombinant human NDR2 (83 to end residues) at 1 uM using RSRSRSRSRSRSRSR as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	33.0	CHEMBL4851	Homo sapiens	INH	%	33.0
	22423209	CHEMBL4674180	Inhibition of human STK38L using KKRNRRLSVA as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	93.25	CHEMBL4851	Homo sapiens	Activity	%	93.25
	22423210	CHEMBL4674180	Inhibition of human STK38L using KKRNRRLSVA as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	76.11	CHEMBL4851	Homo sapiens	Activity	%	76.11
	22843552	CHEMBL4720538	Inhibition of human STK38L using KKRNRRLSVA as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.831	CHEMBL4851	Homo sapiens	IC50	10^-10M	8.31
	22843895	CHEMBL4720881	Inhibition of human STK38L assessed as residual activity using KKRNRRLSVA as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	96.56	CHEMBL4851	Homo sapiens	Activity	%	96.56
	22844933	CHEMBL4721608	Inhibition of wild-type human partial length NDR2 (N34 to E447 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	96.78	CHEMBL4851	Homo sapiens	Activity	%	96.78
	22851515	CHEMBL4723771	Binding affinity to human STK38L assessed as displacement of immobilized ligand at 1 uM by KINOMEscan scanMAX assay relative to control	B	O=C(O)CSc1ncnc2cc(-c3cc4ccccc4s3)sc12		CHEMBL4752776	=	Inhibition	%	71.0	CHEMBL4851	Homo sapiens	INH	%	71.0
	22851525	CHEMBL4723781	Binding affinity to human STK38L assessed as displacement of immobilized ligand by KINOMEscan scanMAX assay relative to control	B	O=C(O)CSc1ncnc2cc(-c3cc4ccccc4s3)sc12		CHEMBL4752776	>	Kd	nM	10000.0	CHEMBL4851	Homo sapiens	Kd	nM	10000.0
	22851535	CHEMBL4723791	Inhibition of human STK38L in presence of ATP at Km level	B	O=C(O)CSc1ncnc2cc(-c3cc4ccccc4s3)sc12		CHEMBL4752776	>	IC50	nM	10000.0	CHEMBL4851	Homo sapiens	IC50	nM	10000.0
	22851539	CHEMBL4723795	Binding affinity to human STK38L incubated for 2 hrs by nano-BRET assay based cellular target engagement assay	B	O=C(O)CSc1ncnc2cc(-c3cc4ccccc4s3)sc12		CHEMBL4752776	>	IC50	nM	10000.0	CHEMBL4851	Homo sapiens	IC50	nM	10000.0
	23120752	CHEMBL4804442	Inhibition of NDR2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	4000.0	CHEMBL4851	Homo sapiens	IC50	uM	4.0
	23120753	CHEMBL4804442	Inhibition of NDR2 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	24200.0	CHEMBL4851	Homo sapiens	IC50	uM	24.2
	23120754	CHEMBL4804442	Inhibition of NDR2 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	16800.0	CHEMBL4851	Homo sapiens	IC50	uM	16.8
	23120755	CHEMBL4804442	Inhibition of NDR2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	8400.0	CHEMBL4851	Homo sapiens	IC50	uM	8.4
	23120756	CHEMBL4804442	Inhibition of NDR2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4868141	=	IC50	nM	-8700.0	CHEMBL4851	Homo sapiens	IC50	uM	-8.7
	23120757	CHEMBL4804442	Inhibition of NDR2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4859660	=	IC50	nM	-9500.0	CHEMBL4851	Homo sapiens	IC50	uM	-9.5
	23121790	CHEMBL4804624	Inhibition of NDR2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL4851	Homo sapiens	INH	%	0.0
	23121791	CHEMBL4804624	Inhibition of NDR2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL4851	Homo sapiens	INH	%	0.0
	23121792	CHEMBL4804624	Inhibition of NDR2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL4851	Homo sapiens	INH	%	0.0
	23121793	CHEMBL4804624	Inhibition of NDR2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL4851	Homo sapiens	INH	%	0.0
	23121794	CHEMBL4804624	Inhibition of NDR2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL4851	Homo sapiens	INH	%	0.0
	23121795	CHEMBL4804624	Inhibition of NDR2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL4851	Homo sapiens	INH	%	0.0
	23122698	CHEMBL4805049	Inhibition of human NDR2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	96.0	CHEMBL4851	Homo sapiens	Activity	%	96.0
	23123393	CHEMBL4805637	Inhibition of human NDR2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL4851	Homo sapiens	Activity	%	100.0
	23123852	CHEMBL4806096	Inhibition of DNA-tagged human NDR2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL4851	Homo sapiens	Activity	%	100.0
	23124876	CHEMBL4806654	Inhibition of human NDR2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	99.0	CHEMBL4851	Homo sapiens	Activity	%	99.0
	23124877	CHEMBL4806654	Inhibition of human NDR2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	36.0	CHEMBL4851	Homo sapiens	Activity	%	36.0
Not Active	23317534	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	95.0	CHEMBL4851	Homo sapiens	% Control	%	95.0
Not Active	23318002	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	81.0	CHEMBL4851	Homo sapiens	% Control	%	81.0
Not Active	23318669	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	65.0	CHEMBL4851	Homo sapiens	% Control	%	65.0
Not Active	23319152	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	87.0	CHEMBL4851	Homo sapiens	% Control	%	87.0
Not Active	23319789	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23320264	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	92.4	CHEMBL4851	Homo sapiens	% Control	%	92.4
Not Active	23320942	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	72.0	CHEMBL4851	Homo sapiens	% Control	%	72.0
Not Active	23321410	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23322040	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	88.0	CHEMBL4851	Homo sapiens	% Control	%	88.0
Not Active	23322508	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23323197	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23323665	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23324519	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23325154	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	96.0	CHEMBL4851	Homo sapiens	% Control	%	96.0
Not Active	23325622	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23326269	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23326737	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	81.0	CHEMBL4851	Homo sapiens	% Control	%	81.0
Not Active	23327437	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	91.0	CHEMBL4851	Homo sapiens	% Control	%	91.0
Not Active	23327905	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	94.0	CHEMBL4851	Homo sapiens	% Control	%	94.0
Not Active	23328492	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23328960	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	89.0	CHEMBL4851	Homo sapiens	% Control	%	89.0
Not Active	23329443	CHEMBL4881150	NDR2(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	100.0	CHEMBL4851	Homo sapiens	% residual kinase activity	%	100.0
Not Active	23329906	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23330374	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23331130	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23331598	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23332185	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	98.9	CHEMBL4851	Homo sapiens	% Control	%	98.9
Not Active	23332651	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23333369	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	93.6	CHEMBL4851	Homo sapiens	% Control	%	93.6
Not Active	23334008	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	86.0	CHEMBL4851	Homo sapiens	% Control	%	86.0
Not Active	23334476	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	94.0	CHEMBL4851	Homo sapiens	% Control	%	94.0
Not Active	23335455	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	87.0	CHEMBL4851	Homo sapiens	% Control	%	87.0
Not Active	23335923	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Slightly Active	23336550	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	45.0	CHEMBL4851	Homo sapiens	% Control	%	45.0
Not Active	23337018	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	70.0	CHEMBL4851	Homo sapiens	% Control	%	70.0
Not Active	23338099	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	91.0	CHEMBL4851	Homo sapiens	% Control	%	91.0
Not Active	23338567	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	81.0	CHEMBL4851	Homo sapiens	% Control	%	81.0
Slightly Active	23339179	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	45.0	CHEMBL4851	Homo sapiens	% Control	%	45.0
Slightly Active	23339647	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	38.0	CHEMBL4851	Homo sapiens	% Control	%	38.0
Slightly Active	23340284	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	34.0	CHEMBL4851	Homo sapiens	% Control	%	34.0
Not Active	23340752	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	50.0	CHEMBL4851	Homo sapiens	% Control	%	50.0
Not Active	23341409	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	99.0	CHEMBL4851	Homo sapiens	% Control	%	99.0
Not Active	23341877	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	90.0	CHEMBL4851	Homo sapiens	% Control	%	90.0
Not Active	23342493	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	79.0	CHEMBL4851	Homo sapiens	% Control	%	79.0
Not Active	23342961	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23343591	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	72.0	CHEMBL4851	Homo sapiens	% Control	%	72.0
Not Active	23344059	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	99.0	CHEMBL4851	Homo sapiens	% Control	%	99.0
Not Active	23344697	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	66.0	CHEMBL4851	Homo sapiens	% Control	%	66.0
Slightly Active	23345270	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	43.0	CHEMBL4851	Homo sapiens	% Control	%	43.0
Not Active	23345738	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	80.0	CHEMBL4851	Homo sapiens	% Control	%	80.0
Not Active	23346315	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23346783	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23347385	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	72.7	CHEMBL4851	Homo sapiens	% Control	%	72.7
Not Active	23347875	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23348454	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	87.0	CHEMBL4851	Homo sapiens	% Control	%	87.0
Not Active	23348922	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	76.0	CHEMBL4851	Homo sapiens	% Control	%	76.0
Not Active	23349509	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	75.0	CHEMBL4851	Homo sapiens	% Control	%	75.0
Not Active	23350127	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	78.0	CHEMBL4851	Homo sapiens	% Control	%	78.0
Not Active	23350595	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	75.0	CHEMBL4851	Homo sapiens	% Control	%	75.0
Not Active	23351200	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	83.0	CHEMBL4851	Homo sapiens	% Control	%	83.0
Not Active	23351668	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	88.0	CHEMBL4851	Homo sapiens	% Control	%	88.0
Not Active	23352692	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	85.0	CHEMBL4851	Homo sapiens	% Control	%	85.0
Not Active	23353160	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	72.0	CHEMBL4851	Homo sapiens	% Control	%	72.0
Not Active	23354042	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23354510	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23355242	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23355710	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	95.0	CHEMBL4851	Homo sapiens	% Control	%	95.0
Not Active	23356346	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23356814	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23357423	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23358070	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	84.0	CHEMBL4851	Homo sapiens	% Control	%	84.0
Not Active	23358538	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Not Active	23359124	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	87.7	CHEMBL4851	Homo sapiens	% Control	%	87.7
Not Active	23359722	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	68.0	CHEMBL4851	Homo sapiens	% Control	%	68.0
Not Active	23360190	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	85.0	CHEMBL4851	Homo sapiens	% Control	%	85.0
Not Active	23360775	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	88.0	CHEMBL4851	Homo sapiens	% Control	%	88.0
Slightly Active	23361243	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	42.0	CHEMBL4851	Homo sapiens	% Control	%	42.0
Not Active	23361816	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	87.0	CHEMBL4851	Homo sapiens	% Control	%	87.0
Slightly Active	23362352	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	49.0	CHEMBL4851	Homo sapiens	% Control	%	49.0
Slightly Active	23362820	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	44.0	CHEMBL4851	Homo sapiens	% Control	%	44.0
Not Active	23364462	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	94.0	CHEMBL4851	Homo sapiens	% Control	%	94.0
Not Active	23364930	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	93.0	CHEMBL4851	Homo sapiens	% Control	%	93.0
Not Active	23365669	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	83.0	CHEMBL4851	Homo sapiens	% Control	%	83.0
Not Active	23366212	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL4851	Homo sapiens	% Control	%	100.0
Slightly Active	23366802	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	44.0	CHEMBL4851	Homo sapiens	% Control	%	44.0
Active	23367270	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	20.0	CHEMBL4851	Homo sapiens	% Control	%	20.0
Not Active	23368148	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	75.0	CHEMBL4851	Homo sapiens	% Control	%	75.0
Not Active	23368616	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	76.0	CHEMBL4851	Homo sapiens	% Control	%	76.0
Not Active	23369215	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	65.0	CHEMBL4851	Homo sapiens	% Control	%	65.0
Not Active	23369683	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	74.0	CHEMBL4851	Homo sapiens	% Control	%	74.0
Not Active	23370651	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	82.0	CHEMBL4851	Homo sapiens	% Control	%	82.0
Not Active	23371119	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	98.0	CHEMBL4851	Homo sapiens	% Control	%	98.0
Slightly Active	23371638	CHEMBL4884599	NanoBRET (SGC-Frankfurt) (STK38L)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1	Non standard unit for type	CHEMBL4591082	>	IC50	µM	25.0	CHEMBL4851	Homo sapiens	IC50	µM	25.0
Slightly Active	23371928	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	40.0	CHEMBL4851	Homo sapiens	% Control	%	40.0
Slightly Active	23372396	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	24.0	CHEMBL4851	Homo sapiens	% Control	%	24.0
	23373747	CHEMBL4885524	NDR2(S38LLGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4851	Homo sapiens	pIC50		6.0
Slightly Active	23375823	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	41.0	CHEMBL4851	Homo sapiens	% Control	%	41.0
Not Active	23376291	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	53.0	CHEMBL4851	Homo sapiens	% Control	%	53.0
Not Active	23376868	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	66.0	CHEMBL4851	Homo sapiens	% Control	%	66.0
Not Active	23377336	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	58.0	CHEMBL4851	Homo sapiens	% Control	%	58.0
Not Active	23378196	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	66.0	CHEMBL4851	Homo sapiens	% Control	%	66.0
Not Active	23378664	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	67.0	CHEMBL4851	Homo sapiens	% Control	%	67.0
Not Active	23379831	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	80.0	CHEMBL4851	Homo sapiens	% Control	%	80.0
Not Active	23380299	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	90.0	CHEMBL4851	Homo sapiens	% Control	%	90.0
Not Active	23380993	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	86.0	CHEMBL4851	Homo sapiens	% Control	%	86.0
Slightly Active	23381641	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	49.0	CHEMBL4851	Homo sapiens	% Control	%	49.0
Slightly Active	23382109	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	48.0	CHEMBL4851	Homo sapiens	% Control	%	48.0
Not Active	23382733	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	73.0	CHEMBL4851	Homo sapiens	% Control	%	73.0
Not Active	23383201	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	75.0	CHEMBL4851	Homo sapiens	% Control	%	75.0
Not Active	23383669	CHEMBL4887325	STK38L (NDR2) Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	125.0	CHEMBL4851	Homo sapiens	% Ctrl	%	125.0
Not Active	23384374	CHEMBL4887969	NDR2(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	5.88	CHEMBL4851	Homo sapiens	% inhibition	%	5.88
Not Active	23385116	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	75.0	CHEMBL4851	Homo sapiens	% Control	%	75.0
Not Active	23385583	CHEMBL4879840	KinomeScan assay: inhibition of NDR2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	75.0	CHEMBL4851	Homo sapiens	% Control	%	75.0
